资料显示，爱旭股份成立于1996年8月，主营业务是研发、生产、销售太阳能电池和组件。 爱旭股份：预计上半年预亏1.7亿–2.8亿元 7月10日晚，爱旭股份（600732）发布2025年半年度业绩预告，公司预计上半年实现归属于母公司所有 者的净亏损1.7亿元至2.8亿元，预计实现扣除非经常性损益后的净亏损4.1亿元至5.2亿元。 所属行业：电力设备–光伏设备–光伏电池组件 长城军工：预计上半年预亏2500万–2950万元 7月10日晚，长城军工（601606）发布2025年半年度业绩预告，公司预计上半年实现归属于上市公司股 东的净亏损2500万元至2950万元，预计实现扣除非经常性损益后的净亏损3500万元至4100万元。 资料显示，长城军工成立于2000年11月，主营业务是军品业务与民品业务。 所属行业：国防军工–地面兵装Ⅱ–地面兵装Ⅲ 长源东谷：预计上半年净利润预增62.65%-88.88% 7月10日晚，长源东谷（603950）发布2025年半年度业绩预告，公司预计上半年实现归属于母公司所有 者的净利润1.55亿元至1.8亿元，同比增长62.65%-88.88%；预计实现扣除非经常性损益后的净利润1.5亿 ...

Group 1 - The major shareholder, Qichuang Tianrui Investment, plans to reduce its stake in Silin Jie by up to 2,000,100 shares, representing a maximum of 3.00% of the total share capital [1] - Qichuang Tianrui currently holds 4,799,500 shares, which is 7.20% of the total share capital, and these shares became tradable on March 14, 2023 [1] - The reduction will occur through centralized bidding and block trading, with specific limits on the number of shares that can be sold within certain time frames [1] Group 2 - Silin Jie was listed on the Sci-Tech Innovation Board on March 14, 2022, with an initial public offering of 16.67 million shares at a price of 65.65 yuan per share [2] - The total funds raised by Silin Jie amounted to 1.094 billion yuan, with a net amount of 975 million yuan after deducting issuance costs, exceeding the original plan by 418 million yuan [2] - The company intended to use the raised funds for expansion projects and operational funding, but the stock is currently trading below its IPO price [2] Group 3 - The total issuance costs for Silin Jie were 119 million yuan, with the lead underwriter, Minsheng Securities, receiving 93.02 million yuan in underwriting fees [3] - The strategic placement involved Minsheng Investment, a subsidiary of the underwriter, which acquired 66,680 shares, amounting to 43.7754 million yuan, with a lock-up period of 24 months [3]

7月9日晚间，沪深两市多家上市公司发布公告，以下是第一财经对一些重要公告的汇总，供投资者 参考。 2025.07. 09 【品大事】 五连板华光环能：公司生产经营活动一切正常 基本面没有发生重大变化 五连板华光环能(600475)发布股票交易风险提示公告称，近5个交易日公司股票累计换手率为 29.41%，接近30%，公司股票可能存在非理性炒作风险。截至目前，公司主要围绕环保与能源两大 领域开展设计咨询、设备制造、工程建设、运营管理、投资等一体化业务。公司生产经营活动一切正 常，内部生产经营秩序正常，基本面没有发生重大变化，主营业务结构未发生重大变化，内外部经营 环境未发生重大变化。 安德利：实控人之一王安向其女王萌转让所持BVI平安90%股权 安德利(605198)公告，公司控股股东China Pingan Investment Holdings Limited（BVI平安）近 期发生股权结构变动，实际控制人之一王安向其女王萌转让其持有的BVI平安90%的股权。此次转让 不涉及通过证券交易所的交易行为，控股股东、实际控制人及其一致行动人持有的公司股份数量、持 股比例及表决权均未发生变化。股权结构变动完成后，B ...

Group 1: Company Announcements - Huayin Power's stock has seen a significant short-term increase, with a cumulative rise of 79.82% since July 1, 2025, which is substantially higher than the industry and Shanghai Composite Index [5] - Zhongyan Chemical's subsidiary acquired natural soda mining rights for 6.80866 billion yuan [6] - Shudao Equipment has terminated the acquisition of a 65.43% stake in Keyi Gas [10] - New Link Electronics expects a net profit of 166 million to 198 million yuan for the first half of 2025, marking a turnaround from a loss of 41.2841 million yuan in the same period last year [12] Group 2: Profit Forecasts - Xian Da Co. anticipates a net profit increase of 2443.43% to 2834.73%, projecting 130 million to 150 million yuan for the first half of 2025 [2] - Shanghai Pharmaceuticals expects a net profit of 4.45 billion yuan for the first half of 2025, a 52% increase from the previous year [3] - Yonghe Co. forecasts a net profit of 255 million to 280 million yuan, representing a year-on-year increase of 126.30% to 148.49% [4] - Xiangyuan Cultural Tourism projects a net profit of 90 million to 97 million yuan, an increase of 51.44% to 63.22% [5] - Ganli Pharmaceutical expects a net profit of 600 million to 640 million yuan, a growth of 100.73% to 114.12% [6] - Jiangshan Co. anticipates a net profit of 300 million to 360 million yuan, reflecting a year-on-year increase of 75.65% to 110.78% [6] - Zhiwei Intelligent expects a net profit of 91.98 million to 112 million yuan, a growth of 62.85% to 99.06% [9] - Wanliyang forecasts a net profit of 270 million to 290 million yuan, an increase of 46.68% to 57.55% [11] - Wohua Pharmaceutical expects a net profit of 37 million to 53 million yuan, a significant increase of 233.89% to 378.27% [14] - Chenguang Biological anticipates a net profit of 202 million to 232 million yuan, a growth of 102.33% to 132.38% [15] - Muyuan Foods expects a net profit of 10.5 billion to 11 billion yuan, a staggering increase of 924.6% to 973.39% [15] - New Beiyang forecasts a net profit of 34.7 million to 38.2 million yuan, a growth of 100% to 120% [16]

Group 1: Company Performance - Northern Rare Earth expects a net profit of 900 million to 960 million yuan for the first half of 2025, representing a year-on-year increase of 1882.54% to 2014.71% [1] - Muyuan Foods anticipates a net profit of 10.5 billion to 11 billion yuan for the first half of 2025, reflecting a year-on-year growth of 924.6% to 973.39% [2] - Hongta Securities projects a net profit of 651 million to 696 million yuan for the first half of 2025, indicating a year-on-year increase of 45% to 55% [3] Group 2: Business Developments - Dazhihui clarifies that it has not engaged in businesses related to "stablecoins," "virtual asset trading," or "cross-border payments," following a significant stock price fluctuation [4] - Bluetech announces a share transfer agreement where its actual controller will change, with the Ma'anshan Municipal Government becoming the actual controller after the transfer of 18% of shares [5] Group 3: Industry Trends - Jiangsu Electric Power reports a 5.01% year-on-year increase in electricity generation for the first half of 2025 [6] - Jin'an Guoji anticipates a non-recurring net profit growth of 4700% to 6300% for the first half of 2025 [6] - New Beiyang expects a non-recurring net profit growth of 650% to 720% for the first half of 2025 [6]

证券代码：688115 证券简称：思林杰 公告编号：2025-034 广州思林杰科技股份有限公司 关于持股 5%以上股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： ? 股东持股的基本情况 截至本公告披露日，横琴启创天瑞投资企业（有限合伙） （以下简称"启创天 瑞"）持有广州思林杰科技股份有限公司（以下简称"思林杰"或"公司"）股份 份，已于 2023 年 3 月 14 日解除限售并上市流通。 ②减持股份的方式 锁定期届满后，本人/本企业拟通过包括但不限于二级市场集中竞价交易、 大宗交易、协议转让等方式减持所持有的公司股份。 ? 减持计划的主要内容 公司于近日收到股东启创天瑞出具的《减持计划告知函》。因其自身资金需 求，启创天瑞计划通过集中竞价、大宗交易方式减持其持有的公司股份不超过 之日起 15 个交易日后的 3 个月内进行。其中，拟通过集中竞价方式减持不超过 过公司总股本的 1.00%；拟通过大宗交易方式减持不超过 1,333,400 股，即不得 超过公司总股本的 2.0 ...

证券代码：688115 证券简称：思林杰 公告编号：2025-034 广州思林杰科技股份有限公司 关于持股 5%以上股东减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律 责任。 重要内容提示： 股东持股的基本情况 截至本公告披露日，横琴启创天瑞投资企业（有限合伙）（以下简称"启创天 瑞"）持有广州思林杰科技股份有限公司（以下简称"思林杰"或"公司"）股份 4,799,500 股，占公司总股本的 7.20%，股份来源于公司首次公开发行前持有的股 份，已于 2023 年 3 月 14 日解除限售并上市流通。 减持计划的主要内容 公司于近日收到股东启创天瑞出具的《减持计划告知函》。因其自身资金需 求，启创天瑞计划通过集中竞价、大宗交易方式减持其持有的公司股份不超过 2,000,100 股，减持比例不超过公司总股本的 3.00%，自本减持股份计划公告披露 之日起 15 个交易日后的 3 个月内进行。其中，拟通过集中竞价方式减持不超过 666,700 股，即不超过公司总股本的 1.00%，且任意连续 90 日减持 ...

Core Viewpoint - The major shareholder of the company, Hengqin Qichuang Tianrui Investment Enterprise (Limited Partnership), plans to reduce its stake in the company due to its own funding needs, starting from July 31, 2025, to October 30, 2025 [1] Summary by Category - **Shareholder Reduction Plan** - The shareholder intends to reduce its holdings by up to 2,000,100 shares, which represents no more than 3% of the company's total share capital [1] - The reduction will occur through two methods: a maximum of 666,700 shares via centralized bidding and up to 1,333,400 shares through block trading [1] - The selling price will be determined based on the market price at the time of the reduction [1]

公司公告汇总 广州思林杰科技股份有限公司发布2024年年度权益分派实施公告。每股派发现金红利0.22元，不涉及差 异化分红送转。相关日期为：股权登记日2025年6月6日，除权（息）日和现金红利发放日均为2025年6 月9日。本次利润分配方案经2025年5月19日的2024年年度股东会审议通过，以方案实施前的公司总股本 66,670,000股为基数，共计派发现金红利14,667,400元。无限售条件流通股的红利委托中国结算上海分公 司派发。对于持有公司无限售条件流通股的自然人股东和证券投资基金，实际派发的现金红利为税前每 股人民币0.22元，根据持股期限计算应纳税额。对于有限售条件流通股个人股东和证券投资基金，解禁 前取得的股息红利实际税负为10%，税后每股实际派发现金红利人民币0.198元。对于持有公司有限售 条件流通股的非居民企业，按10%的税率征收企业所得税，税后每股实际派发现金红利人民币0.198 元。对于合格境外机构投资者（QFII），扣税后实际发放现金红利为每股人民币0.198元。对于持有公 司股票的香港市场投资者，税后每股实际派发现金红利人民币0.198元。对于其他机构投资者和法人股 东，公司实际 ...

Core Points - The company announced a cash dividend of RMB 0.22 per share, totaling RMB 14,667,400 for all shareholders [1][2] - The dividend distribution plan was approved at the annual shareholders' meeting on May 19, 2025 [1] - The dividend will be distributed based on the total share capital of 66,670,000 shares as of the record date [1] Dividend Distribution Details - The cash dividend will be distributed to shareholders registered with China Securities Depository and Clearing Corporation Limited, Shanghai Branch, after the market closes on the record date [2] - Shareholders who have designated trading can receive their cash dividends on the payment date at their designated securities firms [2] - For shareholders who have not designated trading, the dividends will be held by China Securities Depository and Clearing Corporation Limited until they complete the designated trading [2] Taxation Information - For individual shareholders holding unrestricted shares, the actual cash dividend after tax is RMB 0.198 per share, depending on the holding period [3][4] - The tax rates for dividends vary based on the holding period: 20% for holdings of 1 month or less, 10% for holdings between 1 month and 1 year, and no tax for holdings over 1 year [3] - For foreign institutional investors, a 10% withholding tax applies, resulting in an actual cash dividend of RMB 0.198 per share [4][5]